GlassScriptPhysician profile
James Michael Morrow
NPI 1174870406
$21,312.51
in general payments reported to CMS, 2019-2025
42 companies · $2,583 in 2025
The $2,583 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,213 · 2020: $560 · 2021: $1,202 · 2022: $7,310 · 2023: $5,662 · 2024: $782 · 2025: $2,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,900 · Food and Beverage: $3,651 · Travel and Lodging: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,900.00 |
| Food and Beverage | $3,651.38 |
| Travel and Lodging | $1,476.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $8,670.10 | 2022-2025 | |
| Stryker Corporation | $5,916.60 | 2019-2025 | Dart-Fire, Actishield, Easyfuse |
| Biotissue Holdings INC. | $1,917.41 | 2025 | |
| Smith+Nephew, INC. | $1,368.64 | 2019-2025 | Grafix, Bone Anchors With Arthroscopic Delivery System, Stravix |
| Paragon 28, INC. | $936.86 | 2020-2024 | Portfolio, Gorilla, Phantom Hindfoot |
| Horizon Therapeutics Plc | $549.67 | 2019-2021 | |
| Depuy Synthes Sales INC. | $301.14 | 2020-2022 | |
| Melinta Therapeutics, LLC | $194.32 | 2019-2020 | |
| Organogenesis INC. | $172.37 | 2019-2021 | |
| Treace Medical Concepts, INC. | $163.01 | 2022-2025 | |
| Osiris Therapeutics INC. | $120.97 | 2019 | |
| Averitas Pharma INC. | $106.46 | 2023-2024 | Qutenza |
| Legacy Ortho LLC | $102.88 | 2022 | |
| Zimmer Biomet Holdings, INC. | $55.99 | 2019-2020 | |
| Abbvie INC. | $48.63 | 2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $46.69 | 2021-2022 | |
| Integra Lifesciences Corporation | $45.12 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Exact Sciences Corporation | $38.12 | 2023 | Cologuard Collection Kit |
| Wright Medical Technology, INC. | $37.43 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $37.18 | 2021-2025 | Exparel |
| Ibsa Pharma INC. | $36.90 | 2023-2024 | Tirosint, Licart, Licart |
| Paratek Pharmaceuticals, INC. | $35.10 | 2020 | |
| Orthofix Medical, INC. | $34.73 | 2021-2023 | Physio-Stim |
| Bioventus LLC | $34.47 | 2021-2023 | |
| Bone Support INC. | $31.77 | 2024 | Ceramentbone Void Filler, Cerament G |
| Mimedx Group, INC. | $31.24 | 2025 | |
| Novo Nordisk INC | $27.99 | 2019-2022 | |
| Alfasigma USA, INC. | $26.38 | 2021-2022 | |
| Misonix INC | $22.01 | 2020 | |
| Corcept Therapeutics | $20.55 | 2025 | Korlym |
| Kci USA, INC. | $20.16 | 2021 | |
| Lilly USA, LLC | $18.33 | 2024 | Zepbound |
| Hologic Sales and Service, LLC | $17.83 | 2023 | Thinprep 2000 Processor, Aptima |
| Arthrosurface Incorporated | $17.19 | 2019 | |
| Nevro Corp. | $16.47 | 2023 | Senza |
| Baxter Healthcare | $16.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.76 | 2025 | |
| Assertio Therapeutics, INC. | $13.74 | 2020 | |
| Zyla Life Sciences, INC. | $13.13 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.66 | 2022 | |
| Cardiovascular Systems INC. | $11.51 | 2019 | |
| Acell, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.